See more : ExcelFin Acquisition Corp. (XFIN) Income Statement Analysis – Financial Results
Complete financial analysis of Biomerica, Inc. (BMRA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Biomerica, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- Helios Fairfax Partners Corporation (FFXXF) Income Statement Analysis – Financial Results
- Omnichannel Acquisition Corp. (OCA-UN) Income Statement Analysis – Financial Results
- Vietnam Enterprise Investments Limited (VEIL.L) Income Statement Analysis – Financial Results
- Lloyds Banking Group plc (LLOY.L) Income Statement Analysis – Financial Results
- Sourcenext Corporation (4344.T) Income Statement Analysis – Financial Results
Biomerica, Inc. (BMRA)
About Biomerica, Inc.
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies, antigens, or other substances, which exist in the patient's body and stools or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, diabetes, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, an irritable bowel syndrome therapy technology and diagnostic-guided therapy; Helicobacter pylori products, as well as develops, tests, validates, and sells diagnostic products for COVID-19 infection. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.42M | 5.34M | 18.87M | 7.20M | 6.69M | 5.20M | 5.56M | 5.79M | 5.14M | 4.96M | 5.12M | 6.47M | 6.08M | 4.90M | 5.08M | 4.93M | 4.93M | 5.75M | 7.18M | 9.27M | 9.17M | 9.06M | 8.60M | 8.94M | 8.03M | 8.70M | 9.40M | 9.20M | 9.50M | 9.20M | 8.30M | 8.00M | 7.80M | 10.40M | 8.20M | 1.20M | 1.40M | 1.90M | 1.70M |
| Cost of Revenue | 4.80M | 4.89M | 15.89M | 6.70M | 4.91M | 3.91M | 3.81M | 3.77M | 3.62M | 3.42M | 3.45M | 4.05M | 3.78M | 3.37M | 3.51M | 2.96M | 2.79M | 3.50M | 4.78M | 6.19M | 6.25M | 6.16M | 6.06M | 6.13M | 5.40M | 5.10M | 5.30M | 5.20M | 5.10M | 4.80M | 4.30M | 4.80M | 4.80M | 6.70M | 4.00M | 800.00K | 1.00M | 800.00K | 1.20M |
| Gross Profit | 611.00K | 446.00K | 2.98M | 496.98K | 1.78M | 1.29M | 1.75M | 2.02M | 1.52M | 1.54M | 1.67M | 2.43M | 2.30M | 1.53M | 1.56M | 1.97M | 2.14M | 2.25M | 2.41M | 3.09M | 2.92M | 2.90M | 2.54M | 2.81M | 2.63M | 3.60M | 4.10M | 4.00M | 4.40M | 4.40M | 4.00M | 3.20M | 3.00M | 3.70M | 4.20M | 400.00K | 400.00K | 1.10M | 500.00K |
| Gross Profit Ratio | 11.28% | 8.35% | 15.78% | 6.90% | 26.62% | 24.84% | 31.53% | 34.91% | 29.65% | 31.07% | 32.60% | 37.51% | 37.78% | 31.14% | 30.75% | 39.92% | 43.35% | 39.07% | 33.48% | 33.27% | 31.81% | 31.99% | 29.49% | 31.43% | 32.75% | 41.38% | 43.62% | 43.48% | 46.32% | 47.83% | 48.19% | 40.00% | 38.46% | 35.58% | 51.22% | 33.33% | 28.57% | 57.89% | 29.41% |
| Research & Development | 1.49M | 1.58M | 1.81M | 2.41M | 1.91M | 1.68M | 1.40M | 1.13M | 780.33K | 733.64K | 589.87K | 459.09K | 347.13K | 420.57K | 455.17K | 278.31K | 259.09K | 256.10K | 239.00K | 274.29K | 273.98K | 262.84K | 159.76K | 322.12K | 898.12K | 500.00K | 600.00K | 300.00K | 300.00K | 300.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 14.61K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.22K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 5.49M | 6.09M | 5.70M | 4.61M | 2.27M | 2.03M | 1.84M | 1.85M | 1.57M | 1.48M | 1.53M | 1.45M | 1.45M | 1.24M | 1.47M | 1.44M | 1.37M | 1.47M | 2.26M | 3.05M | 2.96M | 2.85M | 2.84M | 3.17M | 5.70M | 3.10M | 3.10M | 2.90M | 3.10M | 3.30M | 3.40M | 3.00M | 3.60M | 4.80M | 3.70M | 1.20M | 1.90M | 2.30M | 2.40M |
| Other Expenses | 0.00 | 1.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.01K | 2.26K | 3.13K | 50.00 | 0.00 | 290.17K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 6.98M | 7.67M | 7.51M | 7.02M | 4.18M | 3.70M | 3.24M | 2.98M | 2.35M | 2.21M | 2.12M | 1.91M | 1.79M | 1.66M | 1.93M | 1.72M | 1.63M | 1.72M | 2.50M | 3.32M | 3.23M | 3.11M | 3.00M | 3.49M | 6.82M | 3.90M | 3.90M | 3.40M | 3.70M | 4.00M | 3.80M | 3.50M | 4.40M | 5.60M | 4.20M | 1.30M | 2.00M | 2.40M | 2.60M |
| Cost & Expenses | 11.78M | 12.56M | 23.41M | 13.72M | 9.10M | 7.61M | 7.05M | 6.75M | 5.97M | 5.63M | 5.57M | 5.96M | 5.58M | 5.03M | 5.44M | 4.69M | 4.42M | 5.23M | 7.28M | 9.51M | 9.48M | 9.27M | 9.06M | 9.62M | 12.22M | 9.00M | 9.20M | 8.60M | 8.80M | 8.80M | 8.10M | 8.30M | 9.20M | 12.30M | 8.20M | 2.10M | 3.00M | 3.20M | 3.80M |
| Interest Income | 431.00K | 133.00K | 26.64K | 66.86K | 71.19K | 44.01K | 47.76K | 46.35K | 24.12K | 21.91K | 17.18K | 10.71K | 8.35K | 7.37K | 14.71K | 29.87K | 33.55K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 26.64K | 367.00 | 9.00 | 47.00 | 37.00 | 282.00 | 167.00 | 0.00 | 142.00 | 302.00 | 1.59K | 5.83K | 12.32K | 27.52K | 49.54K | 35.05K | 0.00 | 0.00 | 0.00 | 0.00 | 40.37K | 0.00 | 0.00 | 0.00 | 0.00 | 100.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 374.00K | 351.00K | 594.82K | 375.86K | 398.63K | 162.91K | 186.60K | 219.22K | 232.42K | 253.28K | 207.03K | 216.71K | 180.12K | 147.81K | 114.01K | 88.65K | 65.83K | 56.74K | 122.05K | 159.32K | 144.16K | 116.55K | 192.42K | 208.99K | 222.33K | 300.00K | 200.00K | 200.00K | 300.00K | 400.00K | 400.00K | 500.00K | 800.00K | 800.00K | 500.00K | 100.00K | 100.00K | 100.00K | 200.00K |
| EBITDA | -5.99M | -6.74M | -3.94M | -7.06M | -2.27M | -2.21M | -1.25M | -689.34K | -563.57K | -393.15K | -219.25K | 741.48K | 795.16K | 313.09K | -218.12K | 383.36K | 1.72M | 537.49K | 24.96K | -75.45K | -171.98K | -93.34K | -273.00K | -408.86K | -3.97M | 0.00 | 400.00K | 800.00K | 1.00M | 800.00K | 600.00K | 200.00K | -600.00K | -1.10M | 800.00K | -800.00K | -1.50M | -1.20M | -1.90M |
| EBITDA Ratio | -110.67% | -128.71% | -20.73% | -84.45% | -28.88% | -42.42% | -22.42% | -11.90% | -10.96% | -7.92% | -4.28% | 11.45% | 11.27% | 6.39% | -4.65% | 7.42% | -11.66% | 9.35% | -0.29% | -1.20% | -2.74% | -1.80% | -2.80% | -5.84% | -50.86% | -3.45% | 2.13% | 7.61% | 10.53% | 8.70% | 7.23% | 1.25% | -8.97% | -10.58% | 9.76% | -75.00% | -178.57% | -57.89% | -105.88% |
| Operating Income | -6.37M | -7.22M | -4.53M | -6.52M | -2.40M | -2.41M | -1.48M | -954.63K | -826.95K | -670.60K | -446.59K | 514.01K | 505.00K | -132.26K | -364.52K | 247.66K | 509.49K | 520.79K | -97.09K | -234.76K | -316.14K | -209.88K | -465.42K | -683.58K | -4.19M | -300.00K | 200.00K | 600.00K | 700.00K | 400.00K | 200.00K | -300.00K | -1.40M | -1.90M | 300.00K | -900.00K | -1.60M | -1.30M | -2.10M |
| Operating Income Ratio | -117.58% | -135.29% | -24.03% | -90.60% | -35.90% | -46.39% | -26.63% | -16.48% | -16.09% | -13.51% | -8.72% | 7.94% | 8.30% | -2.70% | -7.18% | 5.02% | 10.34% | 9.06% | -1.35% | -2.53% | -3.45% | -2.32% | -5.41% | -7.65% | -52.16% | -3.45% | 2.13% | 6.52% | 7.37% | 4.35% | 2.41% | -3.75% | -17.95% | -18.27% | 3.66% | -75.00% | -114.29% | -68.42% | -123.53% |
| Total Other Income/Expenses | 431.00K | 134.00K | 26.64K | 66.50K | 71.18K | 43.97K | 47.73K | 46.07K | 30.97K | 24.16K | 20.17K | 10.46K | 108.45K | 291.71K | 20.07K | 19.52K | 1.13M | 4.99K | 785.00 | 215.24K | 18.91K | -11.77K | -99.19K | 103.21K | 301.56K | 300.00K | -200.00K | 100.00K | 0.00 | 0.00 | 100.00K | 100.00K | 100.00K | 900.00K | -300.00K | 100.00K | 1.00M | -100.00K | -100.00K |
| Income Before Tax | -5.94M | -7.09M | -4.51M | -6.46M | -2.33M | -2.37M | -1.43M | -908.56K | -795.99K | -646.43K | -426.42K | 524.46K | 613.45K | 159.45K | -344.46K | 267.18K | 1.64M | 525.78K | 155.37K | -19.53K | -297.23K | -221.65K | -564.61K | -576.49K | -3.89M | 0.00 | 400.00K | 700.00K | 0.00 | 0.00 | 300.00K | -200.00K | -1.30M | -1.00M | 0.00 | -800.00K | -600.00K | -1.40M | -2.20M |
| Income Before Tax Ratio | -109.62% | -132.78% | -23.88% | -89.68% | -34.84% | -45.55% | -25.77% | -15.69% | -15.49% | -13.03% | -8.33% | 8.10% | 10.09% | 3.25% | -6.79% | 5.41% | 33.35% | 9.15% | 2.16% | -0.21% | -3.24% | -2.45% | -6.57% | -6.45% | -48.40% | 0.00% | 4.26% | 7.61% | 0.00% | 0.00% | 3.61% | -2.50% | -16.67% | -9.62% | 0.00% | -66.67% | -42.86% | -73.68% | -129.41% |
| Income Tax Expense | 42.00K | 51.00K | 23.72K | 13.06K | 7.39K | 24.24K | 31.80K | 46.64K | 703.80K | -315.02K | -210.76K | -12.49K | 65.01K | 2.00K | -13.00K | -87.00K | -67.00K | 16.77K | 1.60K | 1.94K | 1.82K | 2.22K | 2.06K | 2.40K | 2.40K | -200.00K | 100.00K | 200.00K | 300.00K | 300.00K | 300.00K | 100.00K | -500.00K | 200.00K | 600.00K | 0.00 | -1.20M | 0.00 | -200.00K |
| Net Income | -5.98M | -7.14M | -4.53M | -6.47M | -2.34M | -2.39M | -1.47M | -908.56K | -1.50M | -331.41K | -215.66K | 536.96K | 548.44K | 157.45K | -331.46K | 354.18K | 1.71M | 536.88K | 230.27K | 162.26K | -223.20K | -223.87K | -420.74K | -2.67M | -3.89M | -100.00K | 100.00K | 400.00K | 400.00K | 100.00K | 0.00 | -400.00K | -900.00K | -1.20M | -600.00K | -900.00K | -400.00K | -1.30M | -1.90M |
| Net Income Ratio | -110.40% | -133.73% | -24.01% | -89.86% | -34.95% | -46.01% | -26.34% | -15.69% | -29.18% | -6.68% | -4.21% | 8.30% | 9.02% | 3.21% | -6.53% | 7.18% | 34.71% | 9.34% | 3.20% | 1.75% | -2.43% | -2.47% | -4.89% | -29.89% | -48.43% | -1.15% | 1.06% | 4.35% | 4.21% | 1.09% | 0.00% | -5.00% | -11.54% | -11.54% | -7.32% | -75.00% | -28.57% | -68.42% | -111.76% |
| EPS | -0.36 | -0.50 | -0.36 | -0.54 | -0.23 | -0.26 | -0.17 | -0.11 | -0.20 | -0.04 | -0.03 | 0.08 | 0.08 | 0.02 | -0.05 | 0.05 | 0.28 | 0.09 | 0.04 | 0.03 | -0.04 | -0.04 | -0.08 | -0.56 | -0.86 | -0.03 | 0.04 | 0.12 | 0.12 | 0.03 | 0.02 | -0.14 | -0.30 | -0.40 | -0.18 | -0.30 | -0.14 | -0.44 | -0.66 |
| EPS Diluted | -0.36 | -0.50 | -0.36 | -0.54 | -0.23 | -0.26 | -0.17 | -0.11 | -0.20 | -0.04 | -0.03 | 0.07 | 0.08 | 0.02 | -0.05 | 0.05 | 0.25 | 0.08 | 0.03 | 0.03 | -0.04 | -0.04 | -0.08 | -0.56 | -0.86 | -0.03 | 0.03 | 0.10 | 0.12 | 0.03 | 0.02 | -0.14 | -0.30 | -0.40 | -0.18 | -0.30 | -0.14 | -0.44 | -0.66 |
| Weighted Avg Shares Out | 16.82M | 14.15M | 12.67M | 11.93M | 10.17M | 9.21M | 8.57M | 8.26M | 7.50M | 7.55M | 7.19M | 7.02M | 6.89M | 6.67M | 6.65M | 6.62M | 6.13M | 5.93M | 5.76M | 5.75M | 5.74M | 5.30M | 5.10M | 4.81M | 4.54M | 4.00M | 4.00M | 3.86M | 3.59M | 3.33M | 3.33M | 2.86M | 3.00M | 3.00M | 3.33M | 3.00M | 2.86M | 2.95M | 2.88M |
| Weighted Avg Shares Out (Dil) | 16.82M | 14.15M | 12.67M | 11.93M | 10.17M | 9.21M | 8.57M | 8.33M | 7.63M | 7.55M | 7.37M | 7.45M | 7.11M | 6.70M | 6.65M | 7.01M | 6.98M | 6.51M | 6.22M | 6.62M | 5.74M | 5.30M | 5.10M | 4.81M | 4.54M | 4.00M | 4.00M | 3.87M | 3.59M | 3.33M | 3.33M | 2.86M | 3.00M | 3.00M | 3.33M | 3.00M | 2.86M | 2.95M | 2.88M |
Dubai Government Grants Insurance Reimbursement for Biomerica's EZ Detect™ Colorectal Disease Screening Test
Simple 2 minute at-home test detects an early warning sign of colorectal cancer, the third most common cancer worldwide Simple 2 minute at-home test detects an early warning sign of colorectal cancer, the third most common cancer worldwide
Diagnostics Industry Leader Jack Kenny Joins Biomerica's Board of Directors
NEWPORT BEACH, Calif., Aug. 28, 2023 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA), a global biomedical company leading the way in innovative gastroenterology solutions, today announced the appointment of Jack Kenny, former CEO and board member of Meridian Bioscience, Inc.,...
Biomerica Reports Fiscal 2023 Year End Results
IRVINE, Calif., Aug. 25, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical products, today reported its fiscal 2023 financial results.
CVS Health to Begin Nationwide In-Store Sales of Biomerica's EZ Detect™ Colorectal Disease Screening Test
IRVINE, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced that CVS Pharmacy has begun in-store sales rollout of the Company's EZ Detect™ colorectal disease screening test in over 7,000 stores nationwide throughout the...
Biomerica stock leaps as Walmart expands sales of Aware Breast Self Exam to its stores
Shares of Biomerica Inc. BMRA, +7.58% shot up 13.1% toward a 6-month high in active morning trading Friday, after the medical diagnostic products company said Walmart Inc. WMT, +0.45% will start selling its Aware Breast Self Exam device in about...
Walmart to Start Selling Biomerica's Aware Breast Self Exam Devices
Biomerica Inc (NASDAQ: BMRA) announced that its Aware Breast Self Exam device will now be sold in Walmart Inc's (NYSE: WMT) retail system. The Biomerica FDA-cleared Aware Breast Self Exam device is a way for women to enhance tactile sensitivity to changes or.
Recap: Biomerica Q1 Earnings
Biomerica(NASDAQ:BMRA) stock rose by 2.53% on Monday after the company reported its Q1 earnings results on Friday, October 15, 2021 at 06:30 AM. Here's what investors need to know about the announcement.
Walmart to Begin Nationwide In-Store Sales of Biomerica's EZ Detect™ Colorectal Screening Test
IRVINE, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced that Walmart has begun in-store sales and rollout of the Company's EZ Detect™ colorectal disease screening test within the nationwide Walmart retail system. Biomerica...
Biomerica Reports Results for Fiscal First Quarter ended August 31, 2021
IRVINE, Calif., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical products, today reported its first quarter fiscal 2022 financial results.
BMRA Stock: Why It Increased Drastically Today
The stock price of Biomerica, Inc. (NASDAQ: BMRA) increased by over 19% during intraday trading today. This is why it happened.
Source: https://incomestatements.info
Category: Stock Reports